u/valeria_karlsen

origin, destination, carrier, month — post all four or the report is noise

Ordered from the warehouse in Denmark instead of origin and the whole customs question disappeared. 7 days, door to door.

Cardiovascular outcome trials are powered for events, not for weight, and are typically run in a different population with different inclusion criteria. Reading a weight number out of one is reading a secondary endpoint.

I would not draw a line through two points, especially when the second was taken at a different time of day.

This. Intention-to-treat versus completer analysis routinely moves the headline by several points.

the lane is the unit of analysis, not the supplier

Disagree — that figure is from the diabetes programme and you are quoting it as an obesity endpoint.

SURPASS is the diabetes programme and reports glycaemic endpoints

Small fix — the name you are describing is in the wider-market table with almost nothing on file, not in the documented twenty.

Correcting my own post: the payment date was the 14th, not the 4th. The gap is smaller than I made it sound.

Nearly paid a cloned storefront. Caught it because one character in the domain was wrong and I paste rather than type.

Cosigning the seasonality point. February and August on the same lane are different animals.

Split one order across two months on purpose to compare summer and winter. Four days apart, same carrier, same route.

Absolute or relative risk reduction?

Correction: that is the imaging endpoint, not the histological one.

This is the framing the board needs. It is a hepatic programme first.

research material is not approved for human use, which is why the clinical record here is thin

phase 2 finds a dose, phase 3 measures the effect

a lane with four reports is not yet a lane

Spent four months confusing area% and mass% in every post I made here. One explainer thread and it clicked permanently.

How long was the randomised phase before any extension?

a single hs-CRP outside range is a reason to repeat, not to panic

Not convinced. Imaging-based fat fraction is not the same as a histological response and the paper is explicit about that.

Lost money once, years ago, to a shop that pushed hard for a decision the same day. Every time I see that pressure now I close the tab.

Batch number and date of analysis, are both on there?

report it here with dates, not adjectives

draw at the same point in the week if you want comparability

Batch number and date of analysis, are both on there?

draw at the same point in the week if you want comparability

This. Area percent answers "what fraction of what the detector saw was the peak I wanted", and people read it as "how much peptide is in the vial".

Open-label extensions lose their randomisation. Anybody still enrolled at week 104 is a selected group and the numbers describe that group.

HPLC-UV and LC-MS answer different questions

Looked for independent results across this whole site and found almost none. Worth knowing before forming an opinion.

I would not draw a line through two points, especially when the second was taken at a different time of day.

Ask what the stability statement was written against — temperature, light, and whether it was the lyophilised powder or the reconstituted solution. Those are three different claims.

Agreed. Half the arguments on this site are two people quoting different trials at each other without noticing.

Compared myself to a trial mean for about six months before realising the trial arm had dietitian contact every fortnight.

The registered protocol is public. Comparing the registered primary endpoint with the reported one is a two-minute check and it is how outcome switching gets caught.

That is an escalation schedule for an unapproved compound and this board does not host those.

lab reference ranges are not treatment targets

Domain age, registrar and certificate issuance date are all public and take about a minute to check. A site claiming years of history on a months-old domain is the cheapest signal available.